SMARCA4 and small cell lung carcinoma: In contrast to other SCLC subtypes, these SMARCA4-deficient SCLC-Y tumors showed expression of RB1, weak cytokeratin staining and isolated expression of synaptophysin in the absence of other neuroendocrine markers INSM1 and CD56 (Fig. 3; Supplementary Fig. S3A).